• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TRIM47 通过调节 FBP1 的泛素化促进胰腺癌的有氧糖酵解和肿瘤进展。

TRIM47 accelerates aerobic glycolysis and tumor progression through regulating ubiquitination of FBP1 in pancreatic cancer.

机构信息

Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

出版信息

Pharmacol Res. 2021 Apr;166:105429. doi: 10.1016/j.phrs.2021.105429. Epub 2021 Jan 30.

DOI:10.1016/j.phrs.2021.105429
PMID:33529753
Abstract

Increasing studies demonstrated that ubiquitination plays a vital role in the pathogenesis of pancreatic cancer, and targeting regulation of the ubiquitination process is a potential means for cancer treatment. However, the role of tripartite motif 47 (TRIM47) in pancreatic cancer is still unclear. Here, significantly upregulated TRIM47 and decreased FBP1 expressions were found in pancreatic cancer patient tissues and pointed to a lower survival rate. In addition, we show that TRIM47 was upregulated in pancreatic cancer cells and promoted cell proliferation in vitro and in vivo. Mechanistic investigations showed that TRIM47 promoted the aerobic glycolysis of pancreatic cancer cells, which was largely dependent on the direct binding to and ubiquitination of fructose-1, 6-biphosphatase (FBP1). Furthermore, the promotion of TRIM47 on the Warburg effect and pancreatic cancer progression was abolished by the overexpression of FBP1. Therefore, targeting TRIM47/FBP1 axis might provide a novel strategy to suppress the development of pancreatic cancer.

摘要

越来越多的研究表明泛素化在胰腺癌的发病机制中起着至关重要的作用,靶向调节泛素化过程是癌症治疗的一种潜在手段。然而,TRIM47 在胰腺癌中的作用尚不清楚。在这里,我们发现 TRIM47 在胰腺癌患者组织中显著上调,而 FBP1 的表达下调,这与较低的生存率相关。此外,我们还表明 TRIM47 在胰腺癌细胞中上调,并促进体外和体内的细胞增殖。机制研究表明,TRIM47 促进了胰腺癌细胞的有氧糖酵解,这在很大程度上依赖于其与果糖-1,6-二磷酸酶(FBP1)的直接结合和泛素化。此外,通过过表达 FBP1 可以消除 TRIM47 对瓦博格效应和胰腺癌进展的促进作用。因此,靶向 TRIM47/FBP1 轴可能为抑制胰腺癌的发展提供一种新策略。

相似文献

1
TRIM47 accelerates aerobic glycolysis and tumor progression through regulating ubiquitination of FBP1 in pancreatic cancer.TRIM47 通过调节 FBP1 的泛素化促进胰腺癌的有氧糖酵解和肿瘤进展。
Pharmacol Res. 2021 Apr;166:105429. doi: 10.1016/j.phrs.2021.105429. Epub 2021 Jan 30.
2
E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα.E3 泛素连接酶 UBR5 通过降解 C/EBPα 下调 FBP1 促进胰腺癌生长和有氧糖酵解。
Oncogene. 2021 Jan;40(2):262-276. doi: 10.1038/s41388-020-01527-1. Epub 2020 Oct 29.
3
TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.TRIM47 在结直肠癌中上调,促进 SMAD4 的泛素化和降解。
J Exp Clin Cancer Res. 2019 Apr 12;38(1):159. doi: 10.1186/s13046-019-1143-x.
4
NPM1 activates metabolic changes by inhibiting FBP1 while promoting the tumorigenicity of pancreatic cancer cells.NPM1通过抑制FBP1激活代谢变化,同时促进胰腺癌细胞的致瘤性。
Oncotarget. 2015 Aug 28;6(25):21443-51. doi: 10.18632/oncotarget.4167.
5
TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.TRIM47过表达是一个不良预后因素,并且在非小细胞肺癌的致癌过程中起作用。
Oncotarget. 2017 Apr 4;8(14):22730-22740. doi: 10.18632/oncotarget.15188.
6
TRIM47-CDO1 axis dictates hepatocellular carcinoma progression by modulating ferroptotic cell death through the ubiquitin‒proteasome system.TRIM47-CDO1 轴通过泛素-蛋白酶体系统调节铁死亡性细胞死亡来决定肝细胞癌的进展。
Free Radic Biol Med. 2024 Jul;219:31-48. doi: 10.1016/j.freeradbiomed.2024.04.222. Epub 2024 Apr 16.
7
FBP1 enhances the radiosensitivity by suppressing glycolysis via the FBXW7/mTOR axis in nasopharyngeal carcinoma cells.FBP1 通过 FBXW7/mTOR 轴抑制糖酵解增强鼻咽癌细胞的放射敏感性。
Life Sci. 2021 Oct 15;283:119840. doi: 10.1016/j.lfs.2021.119840. Epub 2021 Jul 20.
8
Knockdown of TRIM47 inhibits breast cancer tumorigenesis and progression through the inactivation of PI3K/Akt pathway.敲低 TRIM47 通过抑制 PI3K/Akt 通路抑制乳腺癌的发生发展。
Chem Biol Interact. 2020 Feb 1;317:108960. doi: 10.1016/j.cbi.2020.108960. Epub 2020 Jan 22.
9
The CDK4/6 inhibitor PD0332991 stabilizes FBP1 by repressing MAGED1 expression in pancreatic ductal adenocarcinoma.CDK4/6 抑制剂 PD0332991 通过抑制 MAGED1 的表达稳定 FBP1 在胰腺导管腺癌中的表达。
Int J Biochem Cell Biol. 2020 Nov;128:105859. doi: 10.1016/j.biocel.2020.105859. Epub 2020 Sep 25.
10
TRIM47 activates NF-κB signaling via PKC-ε/PKD3 stabilization and contributes to endocrine therapy resistance in breast cancer.TRIM47通过稳定PKC-ε/PKD3激活NF-κB信号通路,并促进乳腺癌的内分泌治疗耐药性。
Proc Natl Acad Sci U S A. 2021 Aug 31;118(35). doi: 10.1073/pnas.2100784118.

引用本文的文献

1
TRIM47 Facilitates Osteosarcoma Progression via Destabilising FBP1 and Thus Activation of Wnt/β-Catenin Pathway.TRIM47通过使FBP1不稳定并由此激活Wnt/β-连环蛋白信号通路促进骨肉瘤进展。
J Cell Mol Med. 2025 Aug;29(15):e70753. doi: 10.1111/jcmm.70753.
2
Tripartite motif 47 promotes the development of thyroid carcinoma through ADAR ubiquitination.三重基序蛋白47通过腺苷脱氨酶作用的RNA编辑酶(ADAR)泛素化促进甲状腺癌的发展。
Mol Med. 2025 Jul 5;31(1):252. doi: 10.1186/s10020-025-01298-z.
3
TRIM47 promotes head and neck squamous cell carcinoma malignant progression by degrading XAF1 through ubiquitination.
TRIM47 通过泛素化降解 XAF1 促进头颈部鳞状细胞癌的恶性进展。
iScience. 2024 Dec 13;28(1):111590. doi: 10.1016/j.isci.2024.111590. eCollection 2025 Jan 17.
4
TRIM47 promotes hypopharyngeal and laryngeal cancers progression through promoting K63-linked ubiquitination of vimentin.TRIM47通过促进波形蛋白的K63连接泛素化来促进下咽癌和喉癌的进展。
Cancer Sci. 2025 Feb;116(2):367-380. doi: 10.1111/cas.16397. Epub 2024 Nov 25.
5
TRIM47 drives gastric cancer cell proliferation and invasion by regulating CYLD protein stability.TRIM47 通过调节 CYLD 蛋白稳定性促进胃癌细胞增殖和侵袭。
Biol Direct. 2024 Nov 8;19(1):106. doi: 10.1186/s13062-024-00555-1.
6
TRIM47 promotes the Warburg effect and reduces ferroptosis in prostate cancer by FBP1 and FOXO1.TRIM47通过FBP1和FOXO1促进前列腺癌的瓦伯格效应并减少铁死亡。
Transl Androl Urol. 2024 Sep 30;13(9):1991-2004. doi: 10.21037/tau-23-605. Epub 2024 Sep 26.
7
Trim47 prevents hematopoietic stem cell exhaustion during stress by regulating MAVS-mediated innate immune pathway.Trim47通过调节MAVS介导的天然免疫途径来防止应激期间造血干细胞耗竭。
Nat Commun. 2024 Aug 8;15(1):6787. doi: 10.1038/s41467-024-51199-8.
8
TRIM47 silencing inhibits the malignant biological behaviors of prostate cancer cells by regulating MDM2/p53 signaling.沉默 TRIM47 通过调节 MDM2/p53 信号通路抑制前列腺癌细胞的恶性生物学行为。
Cell Biochem Biophys. 2024 Jun;82(2):1567-1578. doi: 10.1007/s12013-024-01308-7. Epub 2024 May 27.
9
ADAM17 variant causes hair loss via ubiquitin ligase TRIM47-mediated degradation.ADAM17 变异通过泛素连接酶 TRIM47 介导的降解导致脱发。
JCI Insight. 2024 May 21;9(13):e177588. doi: 10.1172/jci.insight.177588.
10
Hypoxia-induced P4HA1 overexpression promotes post-ischemic angiogenesis by enhancing endothelial glycolysis through downregulating FBP1.缺氧诱导的 P4HA1 过表达通过下调 FBP1 增强内皮细胞糖酵解促进缺血后血管生成。
J Transl Med. 2024 Jan 18;22(1):74. doi: 10.1186/s12967-024-04872-x.